Advisory
PACE has assembled advisory committees to provide strategic guidance to the programme and expertise to help select and support projects awarded funding.
Strategic Advisory Committee (SAC)
The SAC provides input and advocacy for the programme. Members are cross-sector experts in AMR. The committee provides advice and guidance to the JSB and JPMB on the strategic direction of the programme. Our SAC are not involved in the peer-review of applications for funding and do not provide recommendations on which research projects we should fund.
Professor Till Bachmann
Deputy Head of Infection Medicine & Personal Chair of Molecular Diagnostics and Infection, University of Edinburgh
Dr Ken Bradley
Global Head, Infectious Diseases Discovery Immunology, Roche Pharma Research and Early Development
Sue Charles
Independent Consultant, Charles Consultants; Member of the WHO Task Force of AMR Survivors
Nick Crabb
CSO for Science, Evidence and Analytics, AMR Lead, NICE
Helen Dent
CEO, BIVDA
Dr Erin Duffy
Chief of Research & Development, CARB-X
Professor Sir Michael Ferguson
Regius Professor of Life Sciences, University of Dundee
Professor William Hope
Dame Sally Davies Chair of AMR Research, University of Liverpool
Dr Seamus O'Brien
R&D Director, GARDP
Dr Lesley Ogilvie
Secretariat Director, Global AMR R&D Hub
Dr Deborah O’Neill
CEO, Novabiotics
Dr Maneesh Paul
CEO, Microvioma
Dr Alexander Pym
Director of Infectious Disease, Wellcome
Florence Sejourne
CEO, Aurobac
Professor Mary de Silva
Deputy Chief Scientific Advisor, DHSC
Kirsteen Wills
CEO, AMR Action UK
Scientific Projects Advisory Groups (SPAG)
SPAG members are experts in AMR research and development. They provide scientific review and assessment of research proposals as part of our funding call process and ongoing portfolio monitoring. They provide recommendations and advice to the JPMB. If necessary, more than one SPAG will be convened during the programme to complement the funding round at the time (e.g. therapeutics and diagnostics).
Antibacterial Therapeutics SPAG
Dr Lloyd Czaplewski (Chair)
Independent Consultant, Chemical Biology Ventures Ltd; CSO, Persica
Dr Nel Moore (Deputy Chair)
Independent Consultant, FW East Consulting
Professor Stephen Baker
Professor and Director of Research Global Health, University of Cambridge
Dr Benjamin Blasco
Senior Discovery Manager, GARDP
Dr Patricia Bradford
Independent Consultant, Antimicrobial Development Specialists
Professor Karen Bush
Professor of Practice Emerita, Indiana University Bloomington
Dr Jason Clark
CSO, NexaBiome
Professor Martha Clokie
Professor of Microbiology, University of Leicester
Dr Aleksandar Danilovski
Independent Consultant; DALISCO d.o.o.
Dr Alice Erwin
Independent Consultant, Erwin Consulting LLC
Professor Ian Gilbert
Professor of Drug Discovery, Drug Discovery Unit, University of Dundee
Dr Hideki Maki
Principal Investigator, Shionogi
Dr Ralph Minter
Senior VP of Research, Alchemab Therapeutics Ltd
Dr Claire Sadler
Independent Consultant, Sadler Scientific; Senior Toxicologist, Apconix
Dr Bala Subramanian
CSO, Bugworks
Dr Peter Warn
Independent Consultant, Magic Bullet Consulting
Antibacterial Diagnostics SPAG
Philip Jordan (Chair)
Principal - Licensing and Ventures Manager, Oxford University Innovation Limited, UK
Sabine Dittrich (Deputy)
Professor for Global Public Health, Deggendorf Institute of Technology, Germany
Joy Allen
Head of Market Access and Public Affairs, Roche Diagnostics UK and Ireland
Akhil Bansal
Policy Fellow, Centre for Global Development, UK; Medical Doctor, Royal Free London NHS Foundation Trust, UK
Jane Cunningham
Consultant in Infectious Diseases and Microbiology, University Hospitals Dorset NHS Foundation Trust, UK
Jayne Ellis
Associate Professor in Clinical Microbiology, University of Leeds, UK; Clinical Scientist, Leeds Teaching Hospitals NHS Trust, UK
Nina Garrett
Chief Technical Officer, Abingdon Health, UK
Namita Jaggi
Chairperson, Labs and Infection Control, Artemis Hospitals, India; Medical Doctor, India
Karen Jordan-Coffey
Clinical Marketing Director, bioMérieux UK Ltd, UK
Gorm Lisby
Chief Consultant, Hvidovre Hospital, Copenhagen, Denmark
Colleen Loynachan
Senior Technical Advisor, International Pandemic Preparedness Secretariat, UK
Jonathan Perkins
Independent Consultant and Scientific Advisor, UK
Giles Sanders
Head of Diagnostics, The Technology Partnership (TTP), UK
John Tyson
Head of North-East Innovation Lab, Newcastle Hospitals, UK
Betsy Wonderly-Trainor
Alliance Director, CARB-X, US
Extended Advisory Network
Together with SPAG members, these scientific advisors are part of PACE’s broader expert network. They support our portfolio projects in a range of ways, including participation in scientific advisory boards and the provision of specialist input to help advance projects.
Professor Jo Fothergill
Professor in Medical Microbiology, University of Liverpool
Professor Colin Hill
Professor of Microbiology, University College Cork
Dr Zoltán Magyarics
Vice-President, Research and Development, AOP Health
Dr Margarida Saraiva
Group leader at i3S-Porto, Portugal
AMR Community Representatives Committee (ACRC)
The voices of people with lived experience of AMR are integral to PACE. The ACRC reviews proposals from a patient and public perspective, providing insight, input and feedback to applications submitted as part of our funding calls and as part of ongoing portfolio delivery. In this way we are promoting a more person-centred approach to PACE funded research, resulting in better outcomes for all.
We partnered with Vocal, a non-profit patient and public involvement and engagement organisation that specialises in connecting people to health research, to assemble the ACRC. Vocal hosts a network of people affected by AMR, as either patients or carers, and to date 13 members of this AMR community are involved in the ACRC. Learn more about Vocal and the AMR network.
Apply to join one of the PACE advisory committees
Apply Here